Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis

JHEP Reports(2020)10.1016/j.jhepr.2020.100223Source: DataRank Database

ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis is a research paper published in JHEP Reports (2020). On theSindex it has a DataRank of 0. It has been cited 50 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access50 citations

Download PDF

Cite:

Linked data & code

geo doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 2.31)OA: goldTopics (41)Linked Datasets (18)DataCite Reuse (18)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (14)

Amy P. Chiu ORCID,Barbara R. Tschida ORCID,Lilian H. Lo ORCID,Cynthia H. Chiu ORCID,Xiao-Xiao Li ORCID

Live enrichment

PubMed:33604532 PMC:PMC7873381 OpenAlex:https://openalex.org/W3111471410

University Grants Committee

National Institutes of Health

FWCI

2.31

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.jhep-reports.eu/article/S2589555920301579/pdf

publisherhttp://www.jhep-reports.eu/article/S2589555920301579/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2589555920301579?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2589555920301579?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jhepr.2020.100223

Fields of Study

Peroxisome Proliferator-Activated ReceptorsWnt/β-catenin signaling in development and cancerAldose Reductase and Taurine

Keywords

Cancer researchWnt signaling pathwayKnockout mouseDownregulation and upregulationPeroxisome proliferator-activated receptor gammaLiver cancerHepatocellular carcinomaBiologyOncogeneCancerSignal transductionCell biologyReceptorGeneticsGenePeroxisome proliferator-activated receptorSleeping BeautyCtnnb1Zbtb20PpargHcc, Hepatocellular CarcinomaReverse Genetic ScreenSb, Sleeping BeautyIf, ImmunofluorescenceGsk3b, Glycogen Synthase Kinase 3 BetaFah, Fumarylacetoacetate HydrolaseQpcr, Quantitative Rt-pcrCtnnb1, Catenin Beta 1Afp, Alpha-foetoproteinBtb/poz, Broad ComplexHhl, Immortalized Human Hepatic Cell LineNtbc, 2-(2-Nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedioneOfp, Orange Fluorescent ProteinPhi, Post-hydrodynamic InjectionPok, Poz And KruppelPparg, Peroxisome Proliferator Activated Receptor GammaZbtb20, Zinc Finger And Btb Domain Containing 20Tramtrack, Bric A Brac/poxvirus And Zinc Finger

Sustainable Development Goals

SDG 0: Good health and well-being

Additional file 2 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522682.v1figshare

Additional file 2 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522682figshare

Additional file 3 of Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma

10.6084/m9.figshare.26554883figshare

Additional file 2 of Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma

10.6084/m9.figshare.26554880.v1figshare

Additional file 2 of Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma

10.6084/m9.figshare.26554880figshare

Additional file 1 of Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma

10.6084/m9.figshare.26554877figshare

Additional file 1 of Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma

10.6084/m9.figshare.26554877.v1figshare

Additional file 3 of Identification of ZBTB9 as a potential therapeutic target against dysregulation of tumor cells proliferation and a novel biomarker in Liver Hepatocellular Carcinoma

10.6084/m9.figshare.26554883.v1figshare

Additional file 6 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522697figshare

Additional file 6 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522697.v1figshare

Additional file 3 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522685.v1figshare

Additional file 4 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522688figshare

Additional file 1 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522679figshare

Additional file 4 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522688.v1figshare

Additional file 3 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522685figshare

Additional file 5 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522694.v1figshare

Additional file 1 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522679.v1figshare

Additional file 5 of NAPSB as a predictive marker for prognosis and therapy associated with an immuno-hot tumor microenvironment in hepatocellular carcinoma

10.6084/m9.figshare.20522694figshare

ZBTB20 regulates WNT/CTNNB1 signalling pathway by suppressing PPARG during hepatocellular carcinoma tumourigenesis

FAIR Checklist

Authors (14)

Funding (2 grants)

Impact

Open Access

Topics

Linked Datasets (18)

Annotations (Europe PMC)